Literature DB >> 33453006

Hyperbaric Oxygen Preconditioning Protects Against Cerebral Ischemia/Reperfusion Injury by Inhibiting Mitochondrial Apoptosis and Energy Metabolism Disturbance.

Shun-Da Wang1, Ying-Ying Fu2, Xin-Yuan Han1, Zhi-Jun Yong1, Qing Li1, Zhen Hu1, Zhen-Guo Liu3.   

Abstract

Hyperbaric oxygen (HBO) therapy is considered a safe and feasible method that to provide neuroprotection against ischemic stroke. However, the therapy mechanisms of HBO have not been fully elucidated. We hypothesized that the mechanism underlying the protective effect of HBO preconditioning (HBO-PC) against cerebral ischemia/reperfusion injury was related to inhibition of mitochondrial apoptosis and energy metabolism disorder. To test this hypothesis, an ischemic stroke model was established by middle cerebral artery occlusion (MCAO) in rats. HBO-PC involved five consecutive days of pretreatment before MCAO. In additional experiments, X chromosome-linked inhibitor of apoptosis protein (XIAP) and second mitochondria-derived activator of caspases (SMAC) shRNA and NC plasmids were intraventricularly injected into rat brains after MCAO (2 h). After 24 h, all rats underwent motor function evaluation, which was assessed by modified Garcia scores. TTC staining for the cerebral infarct and cerebral edema, and TUNEL staining for cell apoptosis, were also analyzed. Reactive oxygen species and antioxidative enzymes in rat brains were detected, as well as mitochondrial complex enzyme activities, ATP levels, and Na+/K+ ATPase activity. Western blot was used to detect apoptotic proteins including Bcl-2, Bax, caspase-3, caspase-9, cyc-c, XIAP, and SMAC. HBO-PC remarkably reduced the infarct volume and improved neurological deficits. Furthermore, HBO-PC alleviated oxidative stress and regulated the expression of apoptosis-related proteins. Moreover, HBO-PC inhibited the decrease in ATP levels, mitochondrial complex enzyme activities, and Na+/K+ ATPase activity to maintain stable energy metabolism. XIAP knockdown weakened the protective effect of HBO, whereas SMAC knockdown strengthened its protective effect. The effects of HBO-PC can be attributed to inhibition of ischemia/hypoxia-induced mitochondrial apoptosis and energy metabolism disturbance. The action of HBO-PC is related to the XIAP and SMAC signaling pathways.

Entities:  

Keywords:  Apoptosis; Ischemia stroke; Metabolic disorder; Mitochondrial dysfunction; Neuroprotection; Oxidative stress

Year:  2021        PMID: 33453006     DOI: 10.1007/s11064-020-03219-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  46 in total

1.  Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling.

Authors:  S Claiborne Johnston; Shanthi Mendis; Colin D Mathers
Journal:  Lancet Neurol       Date:  2009-02-21       Impact factor: 44.182

Review 2.  How to make better use of thrombolytic therapy in acute ischemic stroke.

Authors:  Geoffrey A Donnan; Stephen M Davis; Mark W Parsons; Henry Ma; Helen M Dewey; David W Howells
Journal:  Nat Rev Neurol       Date:  2011-06-14       Impact factor: 42.937

Review 3.  Antioxidant strategies in the treatment of stroke.

Authors:  Isabelle Margaill; Michel Plotkine; Dominique Lerouet
Journal:  Free Radic Biol Med       Date:  2005-08-15       Impact factor: 7.376

4.  Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.

Authors:  Bin Zhang; Xiao-jiang Sun; Chi-heng Ju
Journal:  Eur Neurol       Date:  2011-03-03       Impact factor: 1.710

5.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

Review 6.  Early ischemic blood brain barrier damage: a potential indicator for hemorrhagic transformation following tissue plasminogen activator (tPA) thrombolysis?

Authors:  Xinchun Jin; Jie Liu; Wenlan Liu
Journal:  Curr Neurovasc Res       Date:  2014       Impact factor: 1.990

7.  Stroke in the very old: a systematic review of studies on incidence, outcome, and resource use.

Authors:  Tommasina Russo; Giorgio Felzani; Carmine Marini
Journal:  J Aging Res       Date:  2011-08-16

8.  FTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemia.

Authors:  Arthur Liesz; Li Sun; Wei Zhou; Sönke Schwarting; Eva Mracsko; Markus Zorn; Henrike Bauer; Clemens Sommer; Roland Veltkamp
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

Review 9.  Mitochondrial Quality Control and Disease: Insights into Ischemia-Reperfusion Injury.

Authors:  Anthony R Anzell; Rita Maizy; Karin Przyklenk; Thomas H Sanderson
Journal:  Mol Neurobiol       Date:  2017-04-11       Impact factor: 5.590

Review 10.  Diverse roles of mitochondria in ischemic stroke.

Authors:  Jenq-Lin Yang; Sujira Mukda; Shang-Der Chen
Journal:  Redox Biol       Date:  2018-03-09       Impact factor: 11.799

View more
  8 in total

Review 1.  Research Progress on the Role of Sirtuin 1 in Cerebral Ischemia.

Authors:  Yijia Fangma; Haitong Wan; Chongyu Shao; Liang Jin; Yu He
Journal:  Cell Mol Neurobiol       Date:  2022-09-24       Impact factor: 4.231

2.  Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice.

Authors:  Daozhou Liu; Qifeng Ji; Ying Cheng; Miao Liu; Bangle Zhang; Qibing Mei; Menglei Huan; Siyuan Zhou
Journal:  J Nanobiotechnology       Date:  2022-06-03       Impact factor: 9.429

3.  Sphingosine-1-phosphate, a novel TREM2 ligand, promotes microglial phagocytosis to protect against ischemic brain injury.

Authors:  Tengfei Xue; Juan Ji; Yuqin Sun; Xinxin Huang; Zhenyu Cai; Jin Yang; Wei Guo; Ruobing Guo; Hong Cheng; Xiulan Sun
Journal:  Acta Pharm Sin B       Date:  2021-10-22       Impact factor: 14.903

4.  Celastrol Protects against Cerebral Ischemia/Reperfusion Injury in Mice by Inhibiting Glycolysis through Targeting HIF-1α/PDK1 Axis.

Authors:  Mengyuan Chen; Maozhu Liu; Ying Luo; Jun Cao; Fanning Zeng; Lu Yang; Junqing Yang; Tao Tao; Yu Jiang
Journal:  Oxid Med Cell Longev       Date:  2022-01-05       Impact factor: 6.543

5.  Mechanism of lncRNA SNHG16 in oxidative stress and inflammation in oxygen-glucose deprivation and reoxygenation-induced SK-N-SH cells.

Authors:  Xiangyuan Cao; Jingjing Ma; Shaohua Li
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 6.  The Assessment of Endovascular Therapies in Ischemic Stroke: Management, Problems and Future Approaches.

Authors:  Tadeusz J Popiela; Wirginia Krzyściak; Fabio Pilato; Anna Ligęzka; Beata Bystrowska; Karolina Bukowska-Strakova; Paweł Brzegowy; Karthik Muthusamy; Tamas Kozicz
Journal:  J Clin Med       Date:  2022-03-28       Impact factor: 4.241

Review 7.  Medical Gas Therapy for Tissue, Organ, and CNS Protection: A Systematic Review of Effects, Mechanisms, and Challenges.

Authors:  Ross D Zafonte; Lei Wang; Christian A Arbelaez; Rachel Dennison; Yang D Teng
Journal:  Adv Sci (Weinh)       Date:  2022-03-04       Impact factor: 17.521

Review 8.  Regulation of Oxidative Stress by Long Non-coding RNAs in Central Nervous System Disorders.

Authors:  Xiaoman Xu; Yi Zhang
Journal:  Front Mol Neurosci       Date:  2022-06-15       Impact factor: 6.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.